Search

everythinglearnresearchcommunity

for

Search:↓

Hyperandrogenism is a common hormonal disorder in women, often linked to PCOS.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Early diagnosis and treatment of Hidradenitis Suppurativa are important to prevent serious physical and mental effects.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Cinnamon can help manage symptoms of polycystic ovary syndrome, improve menstrual cycles and fertility, and positively affect cholesterol and blood sugar levels, but more research is needed to confirm these effects and find the best dosage.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Quercetin may help with PCOS symptoms, but more research is needed.

Taking selenium supplements during chemotherapy may help reduce side effects and improve health markers in ovarian cancer patients.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

A woman with a rare adrenal tumor and hormonal disorder had improved testosterone levels after surgery, but her menstrual irregularities continued.

A toddler with a rare adrenal gland tumor causing male-like physical changes was successfully treated with surgery.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

The Li-Pa/Ca and Do/Ca chemotherapy regimens for serous ovarian cancer showed better short-term and long-term results than the Pa/Ca regimen.

Eating certain seeds may help reduce symptoms of Polycystic Ovary Syndrome.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

A woman's excessive hair growth was linked to a rare case of high testosterone caused by a prolactin-producing pituitary tumor.

Most patients experienced significant but reversible hair loss during treatment.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Paclitaxel is an effective cancer drug with side effects and potential new uses beyond cancer.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.